Kelly Connolly Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 710 Route 28, Harwich Port, MA 02646 Phone: 508-905-2856 |
Kerry Darling Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 466 Route 28, Harwich Port, MA 02646 Phone: 508-778-1839 |
Thomas Jared Butler, MS, CAGS Counselor Medicare: Not Enrolled in Medicare Practice Location: 710 Route 28, Harwich Port, MA 02646 Phone: 508-432-1400 Fax: 508-487-6298 |
Lisa Michelle Bacon, LMHC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 710 Route 28, Harwich Port, MA 02646 Phone: 508-237-0057 |
News Archive
"The Department of Defense is estimated to have spent more than half a billion dollars to support a variety of global health-related activities in fiscal year 2012 - more than either the Centers for Disease Control and Prevention or the National Institutes of Health dedicated to global health in the same year, according to a new report from the Kaiser Family Foundation," a report summary on the foundation's webpage states.
The anxiety and behavioral issues associated with excess MeCP2 protein result from overexpression of two genes (Crh [corticotropin-releasing hormone] and Oprm 1 [mu-opioid receptor MOR 1]), which may point the way to treating these problems in patients with too much of the protein, said Baylor of Medicine scientists in a report that appears online in the journal Nature Genetics.
Roche announced today the acquisition of Bina Technologies, Inc., a privately held company based in Redwood City, California, USA. Bina provides a big data platform for centralized management and processing of next generation sequencing (NGS) data.
According to the latest research, a drug derived from plant extracts could wipe out tumors in a single treatment with minimal side effects. Scientists have turned a chemical found in crocuses into a ‘smart bomb' that targets cancerous tumors. The advantage is that healthy tissue is unharmed, reducing the odds of debilitating side effects. And unlike other side effect-free drugs, it is able to kill off more than one type of the disease, including breast, prostate, lung and bowel cancer. Potentially, all solid tumours could be vulnerable to drugs developed this way, meaning it could be used against all but blood cancers.
Urologix, a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapyâ„¢ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for its fourth quarter ended June 30, 2010 and for fiscal year 2010.
› Verified 1 days ago